Lower Risk of New Fractures With Teriparatide Compared With Risedronate in Osteoporosis – Rheumatology Advisor

Rheumatology AdvisorLower Risk of New Fractures With Teriparatide Compared With Risedronate in OsteoporosisRheumatology AdvisorTeriparatide is associated with a lower risk for new vertebral and clinical fractures compared with risedronate in post-menopausal women being treated for severe osteoporosis, according to a multicenter double-blind study published in The Lancet.

Source:: Osteoporosis Feed

      

Last modified: November 29, 2017